A defined growth medium for Clostridium difficile

References

1. Banno Y., Kobayashi T., Kono H., Watanabe K., Ueno K., Nozawa Y. 1984; Biochemical characterization and biologic actions of two toxins (D.l and D.2) from Clostridium difficile. . Rev Infect Dis 6: (Suppl 1) S11–S20
   [Google Scholar]
2. Bartlett J. G., Chang T. W., Gurwith M., Gorbach S. L., Onderdonk A. B. 1978a; Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.. New Engl J Med 298:531–534
   [Google Scholar]
3. Bartlett J. G., Moon N., Chang T. W., Taylor N., Onderdonk A. B. 1978b; Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.. Gastroenterology 75:778–782
   [Google Scholar]
4. Borriello S. P., Larson H. E. 1981; Antibiotic and pseudomembranous colitis.. J Antimicrob Chemother 7: (Suppl A) 53–62
   [Google Scholar]
5. Borriello S. P., Davies H. A., Barclay F. E. 1988; Detection of fimbriae amongst strains of Clostridium difficile. . FEMS Microbiol Lett 49:65–67
   [Google Scholar]
6. Boyd M. J., Logan M. A., Tytell A. A. 1948; The growth requirements of Clostridium perfringens (welchii) BP6K.. J Biol Chem 174:1013–1025
   [Google Scholar]
7. Davis H. A., Borriello S. P. 1990; Detection of capsule in strains of Clostridium difficile. . Microbiol Pathog 9:141–146
   [Google Scholar]
8. Fuchs A. R., Bonde G. J. 1957; The nutritional requirements of Clostridium perfringens. . J Gen Microbiol 16:317–329
   [Google Scholar]
9. George W. L., Sutter V. L., Goldstein E. J. C., Ludwig S. L., Finegold S. M. 1978; Aetiology of antimicrobial-agent-associated colitis.. Lancet i802–803
   [Google Scholar]
10. Haslam S. C., Ketley J. M., Mitchell T. J., Stephan J., Burdon D. W., Candy D. C. A. 1986; Growth of Clostridium difficile and production of toxins A and B in complex and defined media.. J Med Microbiol 21:293–297
    [Google Scholar]
11. Honda T., Hernadez I., Katoh T., Miwatani T. 1983; Stimulation of enterotoxin production of Clostridium difficile by antibiotics.. Lancet i 655:
    [Google Scholar]
12. Hubert J., Ionesco H., Sebald M. 1981; Detection of Clostridium difficile on minimal and selective medium and by immunofluorescence antibody staining.. Ann Microbiol (Paris) 132A:149–157
    [Google Scholar]
13. Larson H. E., Price A. B., Honour P., Borriello S. P. 1978; Clostridium difficile and the aetiology of pseudomembranous colitis.. Lancet i:1063–1066
    [Google Scholar]
14. Lyerly D. M., Sullivan N. M., Wilkins T. D. 1983; Enzyme-linked immunosorbent assay for Clostridium difficile toxin A.. J Clin Microbiol 17:72–78
    [Google Scholar]
15. Lyerly D. M., Roberts M. D., Phelps C. J., Wilkins T. D. 1986; Purification and properties of toxins A and B of Clostridium difficile. . FEMS Microbiol Lett 33:31–35
    [Google Scholar]
16. Lyerly D. M., Krivan H. C., Wilkins T. D. 1988; Clostridium difficile., its disease and toxins.. Clin Microbiol Rev 1:1–18
    [Google Scholar]
17. Nakamura S., Mikawa M., Nakashio S., Takabatake M., Okado I., Yamakawa K., Serikawa T., Okumura S., Nishida S. 1981; Isolation of Clostridium difficile from the feces and the antibody in sera of young and elderly adults.. Microbiol Immunol 25:345–351
    [Google Scholar]
18. Nakamura S., Nakashio S., Mikawa M., Yamakawa K., Okumura S., Nishida S. 1982; Antimicrobial susceptibility of Clostridium difficile from different sources.. Microbiol Immunol 26:25–30
    [Google Scholar]
19. Nakamura S., Yamakawa K., Izumi J., Nakashio S., Nishida S. 1985; Germinability and heat resistance of spores of Clostridium difficile strains.. Microbiol Immunol 29:113–118
    [Google Scholar]
20. Seddon S.V., Borriello S.P. 1989; A chemically defined and minimal medium for Clostridium difficile. . Lett Appl Microbiol 9:237–239
    [Google Scholar]
21. Seddon S. V., Hemingway I., Borriello S. P. 1990; Hydrolytic enzyme production by Clostridium difficile and its relationship to toxin production and virulence in the hamster model.. J Med Microbiol 31:169–174
    [Google Scholar]
22. Seddon S. V., Krishna M., Davis H. A., Borriello S. P. 1991; Effect of nutrition on the expression of known and putative virulence factors of Clostridium difficile. . Microb Ecol Flealth Dis 4:303–309
    [Google Scholar]
23. Sonenshein A. L. 1993; Introduction to metabolic pathways.. In Bacillus subtilis and Other Gram-Positive Bacteria : Biochemistry Physiology, and Molecular Genetics, pp 127–132 Edited by Sonenshein A. L., Hoch J. A., Losick R. Washington DC: American Society for Microbiology;
    [Google Scholar]
24. Strelau E., Wagner B., Wagner W., Karsch W. 1989; Demonstration of capsule in strains of Clostridium difficile. . Zentralbl Bakteriol Mikrobiol Hyg Ser A270:456–461
    [Google Scholar]
25. Sullivan N. M., Pellett S., Wilkins T. D. 1982; Purification and characterization of toxins A and B of Clostridium difficile. . Infect Immun 35:1032–1040
    [Google Scholar]
26. Whitmer M. E., Johnson E. A. 1988; Development of improved defined media for Clostridium botulinum serotypes A, B, and E.. Appl Environ Microbiol 54:753–759
    [Google Scholar]